Zika Virus: Medical Countermeasure Development Challenges
- PMID: 26934531
- PMCID: PMC4774925
- DOI: 10.1371/journal.pntd.0004530
Zika Virus: Medical Countermeasure Development Challenges
Abstract
Introduction: Reports of high rates of primary microcephaly and Guillain-Barré syndrome associated with Zika virus infection in French Polynesia and Brazil have raised concerns that the virus circulating in these regions is a rapidly developing neuropathic, teratogenic, emerging infectious public health threat. There are no licensed medical countermeasures (vaccines, therapies or preventive drugs) available for Zika virus infection and disease. The Pan American Health Organization (PAHO) predicts that Zika virus will continue to spread and eventually reach all countries and territories in the Americas with endemic Aedes mosquitoes. This paper reviews the status of the Zika virus outbreak, including medical countermeasure options, with a focus on how the epidemiology, insect vectors, neuropathology, virology and immunology inform options and strategies available for medical countermeasure development and deployment.
Methods: Multiple information sources were employed to support the review. These included publically available literature, patents, official communications, English and Lusophone lay press. Online surveys were distributed to physicians in the US, Mexico and Argentina and responses analyzed. Computational epitope analysis as well as infectious disease outbreak modeling and forecasting were implemented. Field observations in Brazil were compiled and interviews conducted with public health officials.
Conflict of interest statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: RWM and JGM are employees and equity holders in RW Malone MD LLC. JH is an employee and equity holder in ioGenetics LLC. JT is an employee and equity holder in Nanotherapeutics, Inc. RRC is an employee of Nanotherapeutics, Inc.
Figures
![Fig 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4774925/bin/pntd.0004530.g001.gif)
![Fig 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4774925/bin/pntd.0004530.g002.gif)
![Fig 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4774925/bin/pntd.0004530.g003.gif)
Similar articles
-
Overview of Zika infection, epidemiology, transmission and control measures.J Infect Public Health. 2017 Mar-Apr;10(2):141-149. doi: 10.1016/j.jiph.2016.05.007. Epub 2016 Jun 6. J Infect Public Health. 2017. PMID: 27283926 Review.
-
The Convergence of a Virus, Mosquitoes, and Human Travel in Globalizing the Zika Epidemic.J Community Health. 2016 Jun;41(3):674-9. doi: 10.1007/s10900-016-0177-7. J Community Health. 2016. PMID: 26969497 Review.
-
The Zika outbreak of the 21st century.J Autoimmun. 2016 Apr;68:1-13. doi: 10.1016/j.jaut.2016.02.006. Epub 2016 Feb 28. J Autoimmun. 2016. PMID: 26925496 Free PMC article.
-
Zika Virus in the Americas: A Review for Clinicians.Mayo Clin Proc. 2016 Apr;91(4):514-21. doi: 10.1016/j.mayocp.2016.02.017. Mayo Clin Proc. 2016. PMID: 27046524 Review.
-
Identify-Isolate-Inform: A Tool for Initial Detection and Management of Zika Virus Patients in the Emergency Department.West J Emerg Med. 2016 May;17(3):238-44. doi: 10.5811/westjem.2016.3.30188. Epub 2016 Apr 4. West J Emerg Med. 2016. PMID: 27330653 Free PMC article.
Cited by
-
Public Health Strategies in the Face of Crisis: A Comprehensive Review of the Zika Outbreak in India.Cureus. 2024 Apr 20;16(4):e58621. doi: 10.7759/cureus.58621. eCollection 2024 Apr. Cureus. 2024. PMID: 38770475 Free PMC article. Review.
-
New self-sexing Aedes aegypti strain eliminates barriers to scalable and sustainable vector control for governments and communities in dengue-prone environments.Front Bioeng Biotechnol. 2022 Oct 25;10:975786. doi: 10.3389/fbioe.2022.975786. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36394032 Free PMC article.
-
Zika virus as an emerging arbovirus of international public health concern.Osong Public Health Res Perspect. 2022 Oct;13(5):341-351. doi: 10.24171/j.phrp.2022.0101. Epub 2022 Oct 12. Osong Public Health Res Perspect. 2022. PMID: 36328238 Free PMC article.
-
Bridging landscape ecology and urban science to respond to the rising threat of mosquito-borne diseases.Nat Ecol Evol. 2022 Nov;6(11):1601-1616. doi: 10.1038/s41559-022-01876-y. Epub 2022 Oct 27. Nat Ecol Evol. 2022. PMID: 36303000 Review.
-
Therapeutic Application of Genome Editing Technologies in Viral Diseases.Int J Mol Sci. 2022 May 12;23(10):5399. doi: 10.3390/ijms23105399. Int J Mol Sci. 2022. PMID: 35628210 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical